아디포넥틴 ELISA 검사 성능 평가와 한국인의 혈청 아디포넥틴 참고구간 설정
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Adiponectin is a plasma protein secreted by adipose tissues and low serum adiponectin concentration has been reported to be associated with insulin resistance and metabolic syndrome (MS). We evaluated the performance of an ELISA-based assay for measuring serum adiponectin levels and established reference intervals of adiponectin for Korean population. Methods: Laboratory performance, including precision and linearity, of the AdipoMark Human Adiponectin ELISA kit (Mesdia Co., Korea) was assessed. Reference intervals of adiponectin concentration were determined after evaluation of 1200 subjects with no history of MS. Adiponectin was also measured in 100 patients with MS. Results: The mean concentrations of serum samples tested for precision evaluation were 6.66, 12.61, and 23.42 μg/mL: the ELISA showed total imprecision of 13.6%, 9.3%, and 10.5% CV for the respective concentrations. The assay demonstrated linear responses in the range of 1.8-29.9μg/mL serum adiponectin levels. The 95% reference intervals for Korean population were 3.6-19.2 μg/mL for men and 4.5-34.2 μg/mL for women. ROC-area under the curve values of adiponectin for the diagnosis of MS were 0.85 for men and 0.83 for women. Low adiponectin level was independently associated with MS in the multivariate analysis. Conclusions: The adiponectin quantitation assay evaluated in this study showed acceptable laboratory and clinical performances in an ELISA platform. To meet the ever-increasing demand for a reliable assay for measuring adiponectin levels in the study of various metabolic diseases, this assay could be further improved by the automation of the platform.
Abstract
Background: Adiponectin is a plasma protein secreted by adipose tissues and low serum adiponectin concentration has been reported to be associated with insulin resistance and metabolic syndrome (MS). We evaluated the performance of an ELISA-based assay for measuring serum adiponectin levels and established reference intervals of adiponectin for Korean population. Methods: Laboratory performance, including precision and linearity, of the AdipoMark Human Adiponectin ELISA kit (Mesdia Co., Korea) was assessed. Reference intervals of adiponectin concentration were determined after evaluation of 1200 subjects with no history of MS. Adiponectin was also measured in 100 patients with MS. Results: The mean concentrations of serum samples tested for precision evaluation were 6.66, 12.61, and 23.42 μg/mL: the ELISA showed total imprecision of 13.6%, 9.3%, and 10.5% CV for the respective concentrations. The assay demonstrated linear responses in the range of 1.8-29.9μg/mL serum adiponectin levels. The 95% reference intervals for Korean population were 3.6-19.2 μg/mL for men and 4.5-34.2 μg/mL for women. ROC-area under the curve values of adiponectin for the diagnosis of MS were 0.85 for men and 0.83 for women. Low adiponectin level was independently associated with MS in the multivariate analysis. Conclusions: The adiponectin quantitation assay evaluated in this study showed acceptable laboratory and clinical performances in an ELISA platform. To meet the ever-increasing demand for a reliable assay for measuring adiponectin levels in the study of various metabolic diseases, this assay could be further improved by the automation of the platform.
참고문헌 (23)
- Maeda K, "cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)", Biochem Biophys Res Commun, 221, pp.286~289 (1996)
- Arita Y, "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity", Biochem Biophys Res Commun, 257, pp.79~83 (1999)
- Ouchi N, "Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin", Circulation, 100, pp.2473~2476 (1999)
- Okamoto Y, "An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls", Horm Metab Res, 32, pp.47~50 (2000)
- Ouchi N, "Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages", Circulation, 103, pp.1057~1063 (2001)
- Hotta K, "Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients", Arterioscler Thromb Vasc Biol, 20, pp.1595~1599 (2000)
- Yang WS, "Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin", J Clin Endocrinol Metab, 86, pp.3815~3819 (2001)
- Weyer C, "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia", J Clin Endocrinol Metab, 86, pp.1930~1935 (2001)
- Hotta K, "Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys", Diabetes, 50, pp.1126~1133 (2001)
- Rasmussen-Torvik LJ, "Associations of body mass index and insulin resistance with leptin, adiponectin, and the leptin-to-adiponectin ratio across ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA)", Ann Epidemiol, 22, pp.705~709 (2012)
- Liu Q, "Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism", Proc Natl Acad Sci U S A, 109, pp.14568~14573 (2012)
- Behnes M, "Alterations of adiponectin in the course of inflammation and severe sepsis", Shock, 38, pp.243~248 (2012)
- Dalamaga M, "The role of adiponectin in cancer: a review of current evidence", Endocr Rev, 33, pp.547~594 (2012)
- Martos-Moreno GÁ, "Evaluation of a multiplex assay for adipokine concentrations in obese children", Clin Chem Lab Med, 48, pp.1439~1446 (2010)
- Loo BM, "Evaluation of multiplex immunoassays, used for determination of adiponectin, resistin, leptin, and ghrelin from human blood samples, in comparison to ELISA assays", Scand J Clin Lab Invest, 71, pp.221~226 (2011)
- Cangemi G, "Plasma total adiponectin levels in pediatrics: reference intervals calculated as a continuous variable of age", Clin Biochem, 45, pp.1703~1705 (2012)
- Gavrila A, "Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns", J Clin Endocrinol Metab, 88, pp.2838~2843 (2003)
- Shand B, "Biovariability of plasma adiponectin", Clin Chem Lab Med, 44, pp.1264~1268 (2006)
- Pischon T, "Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year", Clin Chem, 49, pp.650~652 (2003)
- Wildman RP, "Associations of testosterone and sex hormone binding globulin with adipose tissue hormones in midlife women", Obesity, (Silver Spring) (2012)
- Riestra P, "Relationship of adiponectin with metabolic syndrome components in pubertal children", Atherosclerosis, 216, pp.467~470 (2011)
- Yoon SJ, "The association between adiponectin and diabetes in the Korean population", Metabolism, 57, pp.853~857 (2008)
- Kazuhiko Kotani, "Leptin:Adiponectin Ratio and Metabolic Syndrome in the General Japanese Population", Annals of Laboratory Medicine, 31(3), pp.162~166 (2011), 대한진단검사의학회